Kiora Pharmaceuticals Inc (KPHMW) — 10-Q Filings

10-Q Filings (6)

• Kiora Swings to Q3 Profit, But 9-Month Loss Deepens Amid Zero Revenue — Nov 7, 2025 Risk: high
  KIORA PHARMACEUTICALS INC reported a net income of $26,806 for the three months ended September 30, 2025, a significant improvement from a net loss of $3,413,32
• Kiora Pharmaceuticals Files Q2 2025 10-Q — Aug 8, 2025 Risk: low
  Kiora Pharmaceuticals, Inc. filed its quarterly report for the period ending June 30, 2025. The company is registered in Delaware and its common stock trades un
• Kiora Pharmaceuticals Files Q1 2025 10-Q — May 9, 2025 Risk: medium
  Kiora Pharmaceuticals Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Eyegate Pharmaceuticals Inc., is in the pharmaceu
• Kiora Pharmaceuticals Files Q3 2024 10-Q — Nov 8, 2024 Risk: medium
  Kiora Pharmaceuticals Inc. filed its 10-Q for the period ending September 30, 2024. The company, formerly known as Eyegate Pharmaceuticals Inc., is based in Enc
• Kiora Pharmaceuticals Files Q2 2024 10-Q — Aug 9, 2024 Risk: medium
  Kiora Pharmaceuticals Inc. filed its 10-Q for the period ending June 30, 2024. The company, formerly known as Eyegate Pharmaceuticals Inc., is in the pharmaceut
• Kiora Pharmaceuticals Inc. Files 10-Q for Period Ending March 31, 2024 — May 10, 2024 Risk: low
  KIORA PHARMACEUTICALS INC (KPHMW) filed a Quarterly Report (10-Q) with the SEC on May 10, 2024. Kiora Pharmaceuticals Inc. filed a 10-Q report for the period en

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX